CellThera
Montreal, Canada· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $180M
Overview
A regenerative medicine company developing advanced cell therapies for tissue repair and restoration.
CardiovascularMusculoskeletalRegenerative Medicine
Technology Platform
A modular cell engineering platform that enhances therapeutic cells' survival, immune evasion, and regenerative capacity through genetic and biomaterial modifications.
Funding History
1Total raised:$180M
Follow-on Offering$180M
Opportunities
Potential to address large, chronic degenerative markets with curative or disease-modifying treatments.
Risk Factors
Faces complex regulatory pathways for engineered cell products, high manufacturing costs, and challenges in scaling production.
Competitive Landscape
Operates in the competitive cell therapy space but aims to lead in 'next-generation' engineered cells with improved functionality.